Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT03005002
- Phase
- PHASE1
- Status
- Completed
Conditions
- MLH1 Gene Mutation
- MSH6 Gene Mutation
- Metastatic Carcinoma in the Liver
- PMS2 Gene Mutation
- Stage IV Colorectal Cancer
- Stage IVA Colorectal Cancer
- Stage IVB Colorectal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Durvalumab — BIOLOGICALGiven IV
- Laboratory Biomarker Analysis — OTHERCorrelative studies
- Tremelimumab — BIOLOGICALGiven IV
Study Details
This pilot clinical trial studies the side effects and how well durvalumab and tremelimumab work in treating patients with microsatellite stable colorectal cancer that has spread to the liver. Monoclonal antibodies, such as durvalumab and tremelimumab, may interfere with the ability of tumor cells to grow and spread.
Key Dates
- Start date
- Jun 28, 2017
- Status verified
- Dec 2018
- Primary completion
- Nov 26, 2019
- Completion
- Nov 26, 2019
Study Design
- Enrollment
- 9 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (durvalumab, tremelimumab)Patients receive durvalumab IV over 60 minutes and tremelimumab IV over 60 minutes on day 1. Treatment repeats every 4 weeks for up to 4 courses in the absence of disease progression or unacceptable toxicity. Beginning at week 17, patients receive durvalumab IV over 60 minutes on day 1. Treatment repeats every 4 weeks for up to 9 courses in the absence of disease progression or unacceptable toxicity.
Primary Outcome Measure
Hepatic tumor response as assessed by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 [ Time Frame: Up to 1 year ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | - |
Find similar trials in Duarte, CA
By research site
Related Studies
- Lynch Syndrome X-Talk of Enteral Mucosa With Immune SystemRecruiting · San Raffaele University · Monrovia, California
- Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast CancerPHASE2 · Recruiting · City of Hope Medical Center · Duarte, California
- An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey